Breathe Biologics

is a regenerative medicine company focused on lung diseases using our licensed and patented umbilical cord derived
true mesenchymal stem cell, termed “JadiCell™”

COPD is a consistently progressive, ultimately fatal disease.

15.7

million Americans (6.4%) reported that they have been diagnosed with COPD

50%

of adults with low pulmonary function were not aware that they had COPD

3.23

million deaths worldwide in 2019. COPD is the third leading cause of death worldwide

90%

of COPD deaths in those under 70 years of age occur in low- and middle-income countries

7th

leading cause of poor health worldwide is COPD

70%

of COPD is smoking related in high-income countries

JadiCell Therapy for COPD IND # 28508
To determine safety and efficacy of intravenously administered allogeneic JadiCell umbilical cord blood mesenchymal stem cells in patients with moderate-to-severe COPD.